Xebio Co., Ltd. reported consolidated earnings results for the second quarter and six months ended September 30, 2016. For the six months, on consolidated basis, reported net sales of JPY 112,985 million compared to JPY 110,829 million a year ago. Operating profit was JPY 5,499 million compared to JPY 5,019 million a year ago. Ordinary profit was JPY 4,832 million compared to JPY 5,192 million a year ago. Net profit was JPY 2,456 million compared to JPY 3,075 million a year ago. Capital expenditure was JPY 2,953 million. Net cash from operating activities was JPY 4,276 million compared to JPY 2,187 million a year ago.

For the three months, on consolidated basis, reported net sales of JPY 54,328 million, operating profit was JPY 1,549 million, ordinary profit was JPY 921 million and net profit was JPY 346 million. Capital expenditure was JPY 7,073 million.

Company provides consolidated earnings guidance for the full year 2017; company expects net sales of JPY 118,878 million, operating profit of JPY 5,677 million, ordinary profit of JPY 5,979 million and net profit of JPY 3,340 million.